A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas

NCT07018752 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T Cells Lymphoma (PTCL)

Interventions

DRUG: roginolisib
DRUG: golcadomide
DRUG: azacitidine

Sponsor

The Lymphoma Academic Research Organisation

Collaborators

[object Object]
[object Object]
[object Object]